Stay updated on Optimal Tenecteplase Dose in Stroke Clinical Trial
Sign up to get notified when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.

Latest updates to the Optimal Tenecteplase Dose in Stroke Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.5.0 replaces the previous v3.4.3.SummaryDifference0.0%

- Check22 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.4.2 is now shown. The previous Revision: v3.4.1 note and a general government funding-status notice were removed.SummaryDifference0.3%

- Check58 days agoChange DetectedA general funding-status notice was added. The page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check65 days agoChange DetectedNew UI/text changes include adding a Show glossary option and updating the footer to display 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The prior footer entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check79 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4 with no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Optimal Tenecteplase Dose in Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.